Pharmaceutical formulation
    5.
    发明申请

    公开(公告)号:US20060068034A1

    公开(公告)日:2006-03-30

    申请号:US11229052

    申请日:2005-09-16

    申请人: Brian Whittle

    发明人: Brian Whittle

    IPC分类号: A61K36/88

    摘要: The invention relates to pharmaceutical formulations, and more particularly to formulations containing cannabinoids for administration via a pump action spray. In particular, the invention relates to pharmaceutical formulations, for use in administration of lipophilic medicaments via mucosal surfaces, comprising: at least one lipophilic medicament, a solvent and a co-solvent, wherein the total amount of solvent and co-solvent present in the formulation is greater than 55% wt/wt of the formulation and the formulation is absent of a self emulsifying agent and/or a fluorinated propellant.

    Pharmaceutical formulation
    9.
    发明授权
    Pharmaceutical formulation 有权
    药物制剂

    公开(公告)号:US06946150B2

    公开(公告)日:2005-09-20

    申请号:US10218989

    申请日:2002-08-14

    申请人: Brian Whittle

    发明人: Brian Whittle

    摘要: The invention relates to pharmaceutical formulations, and more particularly to formulations containing cannabinoids for administration via a pump action spray. In particular, the invention relates to pharmaceutical formulations, for use in administration of lipophilic medicaments via mucosal surfaces, comprising: at least one lipophilic medicament, a solvent and a co-solvent, wherein the total amount of solvent and co-solvent present in the formulation is greater than 55% wt/wt of the formulation and the formulation is absent of a self emulsifying agent and/or a fluorinated propellant.

    摘要翻译: 本发明涉及药物制剂,更具体地涉及含有通过泵作用喷雾给药的大麻素的制剂。 特别地,本发明涉及用于通过粘膜表面施用亲脂性药物的药物制剂,其包含:至少一种亲脂性药物,溶剂和共溶剂,其中存在于溶剂和共溶剂中的溶剂和共溶剂的总量 制剂大于制剂的55重量%/重量,并且制剂不含自乳化剂和/或氟化推进剂。